January 18, 2017 / 5:01 PM / in 10 months

BUZZ-U.S. STOCKS ON THE MOVE-Goldman Sachs, Target, CoLucid, Apricus Biosciences

* Eikon search string for individual stock moves: STXBZ

* The Day Ahead newsletter: tmsnrt.rs/2ggOmBi

* The Morning News Call newsletter: tmsnrt.rs/2fwPLTh

Wall Street was little changed on Wednesday as gains in technology and financial stocks offset losses in shares of retailers.

The Dow Jones Industrial Average was down 0.10 percent at 19,806.77, the S&P 500 was up 0.08 percent at 2,269.64 and the Nasdaq Composite was up 0.10 percent at 5,544.337.

** GOLDMAN SACHS GROUP INC, $233.37, -1.01 pct

The bank reported a nearly fourfold rise in quarterly profit on Wednesday, benefiting from a surge in trading following Donald Trump’s surprise win in the U.S. presidential election.

** TARGET CORP, $67.36, -5.05 pct

The retailer lowered its comparable store sales and earnings forecasts for the fourth quarter, citing “softer-than-expected” holiday sales due to, what the retailer called disappointing traffic and sales trends.

** COLUCID PHARMACEUTICALS INC, $46.25, +32.52 pct

** ELI LILLY AND CO, $77.43, +0.75 pct

Lilly said it would buy the migraine drug developer for about $960 million, bringing back into its fold a promising treatment for migraine, a large, under-treated market.

** APRICUS BIOSCIENCES INC, $3.77, +149.67 pct

The drug developer said Mexico has granted its commercialization partner, Ferring Pharmaceuticals, market approval for the company’s erectile dysfunction cream treatment, vitaros.

** GIGAMON INC, $31.00, -29.63 pct

The network traffic management software maker estimated its fourth-quarter revenue below its prior forecast, due to lower-than-expected product bookings in certain areas.

** SHILOH INDUSTRIES INC, $8.87, +13.86 pct

The automobile components maker turned an adjusted profit in the fourth quarter as it benefitted from a favorable product mix and operational efficiencies.

** NXT-ID INC, $3.11, +16.52 pct

The mobile security service provider expects quarterly revenue of $4.5 million for the three months ended Dec. 31.

** BIG 5 SPORTING GOODS CORP, $15.50, -4.32 pct

The sporting goods retailer reported lower-than-expected fourth-quarter sales on Tuesday, hurt by a tough retail environment over the holiday selling period.

** TUESDAY CORP, $4.65, -7.00 pct

Brokerage Johnson Rice downgrades rating on the off-price retailer’s stock to “hold” from “accumulate.” The company said on Tuesday its COO resigned and it eliminated the COO post.

** SCORPIO BULKERS INC, $6.33, +5.42 pct

Brokerage Evercore ISI upgraded rating on the dry bulk shipping company’s stock to “buy” from “hold.”

** XACTLY CORP, $12.50, +6.84 pct

Brokerage Craig-Hallum Capital Group LLC starts with a “buy” rating on the company whose software helps manage incentive compensation.

** URANIUM RESOURCES, $2.09, -10.44 pct

The uranium producer’s public offering of 1.4 million shares priced at $2.01 per share, represents a 14 percent discount to Tuesday’s close.

** REXX ENERGY CORP, $0.92, +22.91 pct

The oil producer’s two-year plan involves halving its capex in 2017, boosting production, trimming its costs and reducing its leverage ratio.

** BENITEC BIOPHARMA LTD, $2.41, -19.67 pct

The European Commission granted an orphan drug designation to Australian drug developer’s experimental drug, BB-301, for the treatment of a rare muscle wasting disorder.

** JAZZ PHARMACEUTICALS PLC, $127.35, +10.19 pct

The U.S. FDA on Tuesday granted the drugmaker’s petition to not approve any generic version of its sleep disorder drug Xyrem without a labeling package insert related to drug-drug interaction (DDI) with divalproex sodium.

** ATYR PHARMA INC, $3.41, +39.09 pct

The drug developer said its lead treatment, Resolaris, received a Fast Track designation by the FDA for the treatment of limb girdle muscular dystrophy 2B, a genetic disease caused by a toxic loss of function in the dysferlin gene.

** CAMECO CORP, $11.53, -13.11 pct

The Canadian uranium producer said on Tuesday it expected its 2016 adjusted profit to be significantly lower than analysts’ estimates and also said it would cut 120 jobs at three of its uranium mines in 2017.

** NORDSTROM INC, $44.21, -0.38 pct

** JC PENNEY CO, $6.87, -1.08 pct

** KOHL‘S CORP, $41.12, -0.63 pct

Brokerage Credit Suisse upgraded Nordstrom’s stock to “outperform” from “buy”, but downgraded JC Penney and Kohl’s to “underperform” from “neutral.”

** MERCANTILE BANK CORP, $32.91, -7.27 pct

Brokerage Raymond James downgraded the stock to “market perform” from “outperform.” (Compiled by Akankshita Mukhopadhyay in Bengaluru)

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below